Wong Matthew Shiu Hang, Pons Aina, De Sousa Paulo, Proli Chiara, Jordan Simon, Begum Sofina, Buderi Silviu, Lim Eric
Academic Division of Thoracic Surgery, Royal Brompton Hospital, London, UK.
Department of Thoracic Surgery, Royal Brompton and Harefield Hospitals, London, UK.
J Thorac Dis. 2024 Jun 30;16(6):3844-3853. doi: 10.21037/jtd-23-1800. Epub 2024 Jun 19.
Surgical resection is the primary treatment for early-stage lung cancer, but little is known about the outcomes that truly matter to patients. This aim of our study was to identify the aspects of postoperative outcomes that matter most to patients undergoing lung cancer surgery and explore the influence of clinical and demographic factors on their importance ratings.
We performed a cross-sectional study of patients undergoing lung resection for non-small cell lung cancer at our institution from November 2021 to May 2022. Patients were surveyed using a self-developed questionnaire and the European Organisation for Research and Treatment of Cancer core health-related quality of life questionnaire (EORTC QLQ-C30) prior to surgery. Ordinal logistic regression was performed to determine associations between individual patient factors and outcome importance ratings.
Forty patients completed the survey during the study period. Patients prioritized oncologic outcomes, with 95% rating R0 resection and cancer recurrence as "very important". Other important factors included overall survival (90%), postoperative complications (e.g., myocardial infarction: 92.5%, infection: 87.5%), and the need for reoperation (82.5%). Health-related quality of life factors, such as chronic pain (77.5%) and the ability to return to normal physical and exercise levels (75%), were also highly valued. Certain patient clinical and demographic factors demonstrated significant associations with importance placed on certain outcomes. Preoperative health-related quality of life scores did not influence outcome importance ratings.
This study provides insights into the outcomes that matter most to patients undergoing lung cancer surgery. Oncologic outcomes and postoperative complications were prioritized, while scar-related factors were less important. Patient preferences varied based on demographic and clinical factors. Understanding these preferences can enhance shared decision-making and improve patient-centered care in thoracic surgical oncology.
手术切除是早期肺癌的主要治疗方法,但对于真正对患者重要的治疗结果却知之甚少。本研究的目的是确定肺癌手术患者术后结果中对患者最重要的方面,并探讨临床和人口统计学因素对其重要性评分的影响。
我们对2021年11月至2022年5月在我院接受非小细胞肺癌肺切除术的患者进行了一项横断面研究。在手术前,使用自行编制的问卷和欧洲癌症研究与治疗组织核心健康相关生活质量问卷(EORTC QLQ-C30)对患者进行调查。进行有序逻辑回归以确定个体患者因素与结果重要性评分之间的关联。
在研究期间,40名患者完成了调查。患者将肿瘤学结果列为优先事项,95%的患者将R0切除和癌症复发评为“非常重要”。其他重要因素包括总生存期(90%)、术后并发症(如心肌梗死:92.5%,感染:87.5%)以及再次手术的必要性(82.5%)。与健康相关的生活质量因素,如慢性疼痛(77.5%)和恢复正常身体和运动水平的能力(75%),也受到高度重视。某些患者的临床和人口统计学因素与对某些结果的重视程度存在显著关联。术前与健康相关的生活质量评分并未影响结果重要性评分。
本研究深入了解了肺癌手术患者最重要的结果。肿瘤学结果和术后并发症被列为优先事项,而与疤痕相关的因素则不太重要。患者的偏好因人口统计学和临床因素而异。了解这些偏好可以加强共同决策,并改善胸外科肿瘤学中以患者为中心的护理。